CLLS
$2.64
Revenue | $0.16Mn |
Net Profits | $-17.48Mn |
Net Profit Margins | -11278.71% |
Cellectis S.a.’s revenue fell -28.57% since last year same period to $0.16Mn in the Q3 2023. On a quarterly growth basis, Cellectis S.a. has generated -12.92% fall in its revenue since last 3-months.
Cellectis S.a.’s net profit jumped 29.15% since last year same period to $-17.48Mn in the Q3 2023. On a quarterly growth basis, Cellectis S.a. has generated -64.18% fall in its net profits since last 3-months.
Cellectis S.a.’s net profit margin jumped 0.81% since last year same period to -11278.71% in the Q3 2023. On a quarterly growth basis, Cellectis S.a. has generated -88.54% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.31 |
EPS Estimate Current Year | -0.31 |
Cellectis S.a.’s earning per share (EPS) estimates for the current quarter stand at -0.31 - a -43.81% fall from last quarter’s estimates.
Cellectis S.a.’s earning per share (EPS) estimates for the current year stand at -0.31.
Earning Per Share (EPS) | 0 |
Cellectis S.a.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2024. This indicates that the Cellectis S.a. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-08 | -0.31 | 0 | 100% |